Cargando…
Update on the development of a novel dry cow therapy using a bismuth-based intramammary teat seal in combination with the bacteriocin lacticin 3147
Public concerns over the widespread prophylactic use of antibiotics have led to a search for alternatives to dry cow therapy for the prevention of intramammary infections. A popular alternative is to infuse a teat seal at drying-off. The teat seal is a viscous non-antibiotic formulation and when it...
Autores principales: | Crispie, Fiona, Flynn, James, Ross, R Paul, Hill, Colin, Meaney, William J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113822/ https://www.ncbi.nlm.nih.gov/pubmed/21851653 http://dx.doi.org/10.1186/2046-0481-57-11-652 |
Ejemplares similares
-
Dry cow therapy with a non-antibiotic intramammary teat seal - a review
por: Crispie, Fiona, et al.
Publicado: (2004) -
Pharmaceutical design of a delivery system for the bacteriocin lacticin 3147
por: Ryan, Aoibhín, et al.
Publicado: (2021) -
Manipulation of charged residues within the two‐peptide lantibiotic lacticin 3147
por: Deegan, Lucy H., et al.
Publicado: (2010) -
The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria
por: Draper, Lorraine A, et al.
Publicado: (2013) -
The Lantibiotic Lacticin 3147 Prevents Systemic Spread of Staphylococcus aureus in a Murine Infection Model
por: Piper, Clare, et al.
Publicado: (2012)